Explore more topics
SEC Form 4 research

Intellia Therapeutics, Inc. insider transactions

Inspect Intellia Therapeutics, Inc.'s public SEC insider acquisitions and sales, reporting owners and source receipts.

As of 2026-10-15T08:02:39.132Z

Issuer CIK
0001652130
Reporting owners
55
Officers and directors
25
Jump to a section

What is a Form 4?

Animation: what a Form 4 is, shown with one real example. Sonic Automotive (SAH) reporting owner Paul P. Rusnak bought 13,701 shares at $59.78 on Wednesday, October 7, 2026, transaction code P, an open-market purchase (S is a sale and A is an award from the company). A timeline marks the SEC's two-business-day filing deadline, which ends Friday, October 9. The SEC accepted the Form 4 at 4:33:21 PM ET on October 9, and NexusTrade treats it as public one minute later, at 4:34:21 PM ET. A lamp for NexusTrade's InsiderTrades indicator stays off from the trade date until that moment, then counts one purchase worth 13,701 × $59.78 = $819,045.78.
In this example the shares were bought on Oct 7, 2026, and NexusTrade's InsiderTrades indicator can count the purchase starting at 4:34:21 PM ET on Oct 9, one minute after the SEC accepted the Form 4.

A Form 4 is the SEC filing a company insider, such as an officer, director or 10% owner, uses to report a trade in the company's stock, generally within two business days. The animation follows one real filing as an example: Paul P. Rusnak's purchase of Sonic Automotive (SAH) shares on October 7, 2026.

The same reading applies to every row on this page. The trade date is when the shares changed hands. The available date is when NexusTrade treats the filing as public, and a NexusTrade InsiderTrades indicator counts a purchase (code P) or sale (code S) only from that moment. Code A awards are not counted as purchases.

Read one actual disclosure before using it

Show the table · 1 row, 7 columns

Scroll sideways to compare all columns. Select a heading to sort.

2026-10-062026-10-02Dube Michael PS1,864$12.43Not reported

First displayed source row from Recent insider disclosures. The full bounded history and coverage notes remain below.

The displayed observation date is 2026-10-02 and its public availability date is 2026-10-06. Subtracting those calendar dates gives 4 days of disclosure lag. Historical public research can use the record from the availability date, rather than backdating knowledge to the observation date. The calendar-day difference does not assert an intraday publication time.

This row is code S: a sale. A purchase-following rule excludes this sale even if the reported dollar amount is large.

Open the linked original receipts to verify the row, then inspect a second record before drawing a pattern. This public filing observation supplies source evidence, not a completed copy-trading return.

SEC accession 0001193125-26-415541 ↗SEC accession 0001193125-26-363567 ↗SEC accession 0001193125-26-363567 ↗

Recent insider disclosures

This table includes purchases, sales and awards in the public filing record. Awards and open-market purchases are distinct transaction codes. For historical research, use the public availability date to determine when the transaction was knowable.

Read code P as a purchase, S as a sale and A as an award. An award is an acquisition, but it is not an open-market purchase. Open the filing receipt to check the transaction details.

Show the table · 4 rows, 7 columns

Scroll sideways to compare all columns. Select a heading to sort.

2026-10-062026-10-02Dube Michael PS1,864$12.43Not reported
2026-08-252026-08-21LEONARD JOHN MS2,785$13Not reported
2026-08-252026-08-20LEONARD JOHN MS19,890$12.6Not reported
2026-07-252026-07-22Dulac Edward J IIIS8,111$11.25Not reported

Most recent 90-day source activity, up to 50 rows. No rows means no matching recent records, not no historical activity.

Officers and directors in the directory

Inspect all 27 displayed rows: Officers and directors in the directory

Scroll sideways to compare all columns. Select a heading to sort.

CHASE WILLIAM J000156357211
LEONARD JOHN M000156358467
DORSA CAROLINE000118117484
Cohen Fred E000133935817
Dulac Edward J III000182153021
GORDON CARL L0001282930152
Bhanji Muna000184690515
FORMELA JEAN FRANCOIS000103057592
Bermingham Nessan00013777595
Hicks Derek00019012823
OrbiMed Capital GP V LLC0001615374113
BASTA JAMES00017927268
Clark Eliana000191444815
Crowley John F0001400973388
Dube Michael P00020194937
Goddard Glenn000158199238
GOODMAN JESSE00017569292
ISALY SAMUEL D0001055949417
KARSEN PERRY A000126057313
Lebwohl David000181088221
ORBIMED ADVISORS LLC00010559511,020
OrbiMed Global Healthcare GP LLC00016738924
Rivera Jose E000167187047
SCHIERMEIER ANDREW00017384563
Schultes Birgit C00020514192
Sepp-Lorenzino Laura000177742124
Verwiel Frank00015457941
CHASE WILLIAM J ↗LEONARD JOHN M ↗DORSA CAROLINE ↗Cohen Fred E ↗Dulac Edward J III ↗GORDON CARL L ↗Bhanji Muna ↗FORMELA JEAN FRANCOIS ↗Bermingham Nessan ↗Hicks Derek ↗OrbiMed Capital GP V LLC ↗BASTA JAMES ↗Clark Eliana ↗Crowley John F ↗Dube Michael P ↗Goddard Glenn ↗GOODMAN JESSE ↗ISALY SAMUEL D ↗KARSEN PERRY A ↗Lebwohl David ↗ORBIMED ADVISORS LLC ↗OrbiMed Global Healthcare GP LLC ↗Rivera Jose E ↗SCHIERMEIER ANDREW ↗Schultes Birgit C ↗Sepp-Lorenzino Laura ↗Verwiel Frank ↗

Which transactions qualify for the company tracker

The company strategy uses verified officers and directors with qualifying acquisitions at this issuer. Other reporting owners may appear in source records without becoming strategy signals.

Strategy eligibility is held while filing coverage is unresolved.

Historical follower simulations are separate from these source transactions. They do not establish live trading results.